Lucid Diagnostics (LUCD) Assets (QoQ) (2021 - 2026)
Lucid Diagnostics (LUCD) Assets (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | Lucid Diagnostics | 176.20 Mn | 142.80 Mn | 55,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.28% |
| Mar 31, 2026 | -15.74% |
| Dec 31, 2025 | -23.97% |
| Sep 30, 2025 | 37.57% |
| Jun 30, 2025 | 17.91% |
| Mar 31, 2025 | 6.77% |
| Dec 31, 2024 | 35.92% |
| Sep 30, 2024 | -33.76% |
| Jun 30, 2024 | 6.44% |
| Mar 31, 2024 | 17.52% |
| Dec 31, 2023 | -17.97% |
| Sep 30, 2023 | -21.75% |
| Jun 30, 2023 | -13.51% |
| Mar 31, 2023 | 51.11% |
| Dec 31, 2022 | -15.29% |
| Sep 30, 2022 | -15.47% |
| Jun 30, 2022 | -26.84% |
| Mar 31, 2022 | 5.19% |
| Dec 31, 2021 | 1,689.85% |